Get the Stockscreener App
32.33
11.71%
3.39
After Hours:
32.04
-0.29
-0.90%
Neurogene Inc Stock (NGNE) Forecast
The Neurogene Inc (NGNE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $129.86, representing a +301.66% increase from the current price of $32.33. The highest analyst price target is $158.19, and the lowest is $101.53.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NGNE Price Target
Average 154.45
(+377.72% Upside)
Is Neurogene Inc (NGNE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 75.47 | Sell |
| STOCH(9,6) | 61.03 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 2.0311 | Buy |
| ADX(14) | 28.83 | Buy |
| William %R | -10.24 | Sell |
| CCI(14) | 92.81 | Neutral |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
27.74
Buy
|
28.03
Buy
|
| MA20 |
25.91
Buy
|
26.36
Buy
|
| MA50 |
23.10
Buy
|
23.76
Buy
|
| MA100 |
20.90
Buy
|
22.43
Buy
|
| MA200 |
21.94
Buy
|
21.31
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, NGNE could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on NGNE, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 75.47 indicates that NGNE is overbought. This suggests that NGNE price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 61.03 indicates that NGNE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that NGNE is oversold. This suggests that NGNE price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.83 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 92.81 indicates that NGNE is still overbought but not to an extreme extent.
Long-term NGNE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Neurogene Inc financial reports and earnings history, Neurogene Inc (NGNE) stock could reach $328.82 by 2030, $689.66 by 2040 and $1,535.18 by 2050. See the projected annual prices until 2050 of the Neurogene Inc stock below:
- Neurogene Inc (NGNE) is expected to reach an average price of $531.49 in 2035, with a high prediction of $533.42 and a low estimate of $478.31. This indicates an $1,544% rise from the last recorded price of $32.33.
- Neurogene Inc (NGNE) stock is projected to chart a bullish course in 2040, with an average price target of $688.52, representing an $2,030% surge from its current level. The forecast ranges from a conservative $630.40 to a sky-high $689.66.
- Our analysts predict Neurogene Inc (NGNE) to jump 2,444% by 2045, soaring from $734.69 to an average price of $822.44, potentially reaching $825.60. While $734.69 is the low estimate, the potential upside is significant.
- Neurogene Inc (NGNE) stock is expected to climb by 2050, reaching an average of $911.56, a $2,720% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,535.18 and $907.37, respectively, highlighting the market's uncertainty.
Neurogene Inc Stock (NGNE) Year by Year Forecast
Neurogene Inc Stock (NGNE) Price Forecast for 2026
The predicted value for Neurogene Inc (NGNE) in 2026 is set at an average of $135.66. Estimates vary from a peak of $184.18 to a trough of $87.14, indicating an +319.62% surge from the present price of $32.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2026 | $112.20 | $101.53 | $158.19 | +247.06% |
| July, 2026 | $134.79 | $115.75 | $135.93 | +316.93% |
| August, 2026 | $146.55 | $135.63 | $148.48 | +353.30% |
| September, 2026 | $180.95 | $148.97 | $182.71 | +459.70% |
| October, 2026 | $171.67 | $168.69 | $184.18 | +430.98% |
| November, 2026 | $127.08 | $115.92 | $182.77 | +293.07% |
| December, 2026 | $152.10 | $131.11 | $153.23 | +370.46% |
Neurogene Inc Stock (NGNE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Neurogene Inc (NGNE) is $187.01, with a high forecast of $243.70 and a low forecast of $130.31. This indicates an +478.43% increase from the last price of $32.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $165.80 | $153.42 | $167.73 | +412.83% |
| February, 2027 | $198.21 | $168.71 | $201.33 | +513.07% |
| March, 2027 | $195.28 | $191.82 | $206.35 | +504.04% |
| April, 2027 | $141.96 | $130.31 | $207.36 | +339.08% |
| May, 2027 | $164.71 | $146.47 | $169.28 | +409.46% |
| June, 2027 | $185.04 | $166.83 | $186.97 | +472.36% |
| July, 2027 | $219.40 | $188.44 | $222.52 | +578.61% |
| August, 2027 | $215.55 | $214.96 | $228.51 | +566.71% |
| September, 2027 | $156.83 | $144.70 | $231.95 | +385.09% |
| October, 2027 | $181.53 | $161.83 | $186.10 | +461.48% |
| November, 2027 | $199.00 | $184.14 | $199.34 | +515.53% |
| December, 2027 | $240.58 | $202.49 | $243.70 | +644.15% |
Neurogene Inc Stock (NGNE) Price Forecast for 2028
In 2028, Neurogene Inc (NGNE) is projected to reach an average price of $232.41, with a high projection of $305.72 and a low estimate of $159.09. This indicates an +618.85% rise from the last price of $32.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $238.68 | $238.09 | $250.67 | +638.26% |
| February, 2028 | $163.28 | $159.09 | $256.54 | +405.04% |
| March, 2028 | $198.34 | $167.76 | $202.91 | +513.50% |
| April, 2028 | $217.76 | $201.44 | $218.10 | +573.56% |
| May, 2028 | $261.77 | $221.74 | $264.89 | +709.70% |
| June, 2028 | $261.81 | $261.22 | $272.83 | +709.81% |
| July, 2028 | $177.67 | $173.48 | $281.13 | +449.55% |
| August, 2028 | $215.16 | $182.63 | $219.73 | +565.52% |
| September, 2028 | $236.52 | $218.74 | $236.86 | +631.59% |
| October, 2028 | $265.27 | $240.98 | $266.71 | +720.51% |
| November, 2028 | $284.94 | $269.63 | $294.99 | +781.36% |
| December, 2028 | $192.06 | $187.87 | $305.72 | +494.06% |
Neurogene Inc Stock (NGNE) Price Forecast for 2029
The 2029 price forecast for Neurogene Inc Stock (NGNE) is $276.20 on average, with a high prediction of $354.90 and a low estimate of $197.51. This represents an +754.33% increase from the previous price of $32.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $231.98 | $197.51 | $236.55 | +617.54% |
| February, 2029 | $255.28 | $236.05 | $255.62 | +689.62% |
| March, 2029 | $285.98 | $260.23 | $287.42 | +784.55% |
| April, 2029 | $311.46 | $290.82 | $317.15 | +863.37% |
| May, 2029 | $206.45 | $202.26 | $330.31 | +538.57% |
| June, 2029 | $244.03 | $212.38 | $244.77 | +654.79% |
| July, 2029 | $267.04 | $248.54 | $270.99 | +725.98% |
| August, 2029 | $306.68 | $272.53 | $308.12 | +848.59% |
| September, 2029 | $334.10 | $312.01 | $339.31 | +933.42% |
| October, 2029 | $220.84 | $216.65 | $354.90 | +583.08% |
| November, 2029 | $260.36 | $227.26 | $261.10 | +705.31% |
| December, 2029 | $285.32 | $265.36 | $289.26 | +782.51% |
Neurogene Inc Stock (NGNE) Price Forecast for 2030
Neurogene Inc Stock (NGNE) is expected to reach an average price of $318.42 in 2030, with a high forecast of $405.79 and a low forecast of $231.04. This signifies an +884.89% surge from the last price of $32.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $327.38 | $291.29 | $328.82 | +912.63% |
| February, 2030 | $356.75 | $333.20 | $361.47 | +1,003% |
| March, 2030 | $366.62 | $353.75 | $379.49 | +1,034% |
| April, 2030 | $267.80 | $231.04 | $270.96 | +728.32% |
| May, 2030 | $303.59 | $273.71 | $307.54 | +839.04% |
| June, 2030 | $340.52 | $310.05 | $343.45 | +953.27% |
| July, 2030 | $379.40 | $343.66 | $383.63 | +1,074% |
| August, 2030 | $390.48 | $376.88 | $404.08 | +1,108% |
| September, 2030 | $283.64 | $245.43 | $286.80 | +777.33% |
| October, 2030 | $321.87 | $290.04 | $325.81 | +895.57% |
| November, 2030 | $360.74 | $328.81 | $363.67 | +1,016% |
| December, 2030 | $395.88 | $364.37 | $405.79 | +1,125% |
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):